Avidity Biosciences, Inc. (RNAM)

72.82 +1.47 (+2.07%) USD  |  NASDAQ  |  Feb 27, 16:00
More

Avidity Biosciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RNAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Novartis AG Upgrade
Dyne Therapeutics, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Insmed, Inc. Upgrade
Revolution Medicines, Inc. Upgrade